nodes	percent_of_prediction	percent_of_DWPC	metapath
Mianserin—OPRK1—Progesterone—uterine cancer	0.323	0.487	CbGbCtD
Mianserin—CYP1A2—Progesterone—uterine cancer	0.0716	0.108	CbGbCtD
Mianserin—CYP2D6—Progesterone—uterine cancer	0.059	0.089	CbGbCtD
Mianserin—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0566	0.0854	CbGbCtD
Mianserin—CYP3A4—Progesterone—uterine cancer	0.0375	0.0566	CbGbCtD
Mianserin—CYP2B6—Doxorubicin—uterine cancer	0.0373	0.0562	CbGbCtD
Mianserin—CYP1A2—Etoposide—uterine cancer	0.032	0.0483	CbGbCtD
Mianserin—CYP2D6—Doxorubicin—uterine cancer	0.018	0.0272	CbGbCtD
Mianserin—CYP3A4—Etoposide—uterine cancer	0.0168	0.0253	CbGbCtD
Mianserin—CYP3A4—Doxorubicin—uterine cancer	0.0114	0.0173	CbGbCtD
Mianserin—HTR1D—artery—uterine cancer	0.00445	0.0581	CbGeAlD
Mianserin—HTR7—artery—uterine cancer	0.00355	0.0463	CbGeAlD
Mianserin—HTR2A—artery—uterine cancer	0.00221	0.0288	CbGeAlD
Mianserin—Jaundice—Progesterone—uterine cancer	0.002	0.00805	CcSEcCtD
Mianserin—HTR2B—myometrium—uterine cancer	0.002	0.0261	CbGeAlD
Mianserin—OPRK1—female reproductive system—uterine cancer	0.00199	0.026	CbGeAlD
Mianserin—Hepatobiliary disease—Progesterone—uterine cancer	0.00194	0.00781	CcSEcCtD
Mianserin—Lethargy—Dactinomycin—uterine cancer	0.00192	0.00773	CcSEcCtD
Mianserin—Weight increased—Medroxyprogesterone Acetate—uterine cancer	0.0019	0.00764	CcSEcCtD
Mianserin—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.00186	0.00749	CcSEcCtD
Mianserin—Hepatitis—Progesterone—uterine cancer	0.00185	0.00742	CcSEcCtD
Mianserin—Jaundice—Medroxyprogesterone Acetate—uterine cancer	0.00182	0.0073	CcSEcCtD
Mianserin—Connective tissue disorder—Progesterone—uterine cancer	0.00181	0.00729	CcSEcCtD
Mianserin—Hepatobiliary disease—Medroxyprogesterone Acetate—uterine cancer	0.00176	0.00708	CcSEcCtD
Mianserin—Eye disorder—Progesterone—uterine cancer	0.00172	0.00693	CcSEcCtD
Mianserin—Tinnitus—Progesterone—uterine cancer	0.00172	0.00691	CcSEcCtD
Mianserin—Cardiac disorder—Progesterone—uterine cancer	0.00171	0.00688	CcSEcCtD
Mianserin—Bradycardia—Medroxyprogesterone Acetate—uterine cancer	0.0017	0.00684	CcSEcCtD
Mianserin—Angiopathy—Progesterone—uterine cancer	0.00167	0.00673	CcSEcCtD
Mianserin—Hepatitis—Medroxyprogesterone Acetate—uterine cancer	0.00167	0.00672	CcSEcCtD
Mianserin—Mediastinal disorder—Progesterone—uterine cancer	0.00166	0.00668	CcSEcCtD
Mianserin—Connective tissue disorder—Medroxyprogesterone Acetate—uterine cancer	0.00164	0.0066	CcSEcCtD
Mianserin—Mental disorder—Progesterone—uterine cancer	0.00162	0.0065	CcSEcCtD
Mianserin—ADRA2C—myometrium—uterine cancer	0.00157	0.0205	CbGeAlD
Mianserin—Eye disorder—Medroxyprogesterone Acetate—uterine cancer	0.00156	0.00628	CcSEcCtD
Mianserin—Bone marrow depression—Epirubicin—uterine cancer	0.00156	0.00627	CcSEcCtD
Mianserin—Tinnitus—Medroxyprogesterone Acetate—uterine cancer	0.00156	0.00627	CcSEcCtD
Mianserin—HTR2B—uterine cervix—uterine cancer	0.00156	0.0203	CbGeAlD
Mianserin—Cardiac disorder—Medroxyprogesterone Acetate—uterine cancer	0.00155	0.00624	CcSEcCtD
Mianserin—Pancytopenia—Dactinomycin—uterine cancer	0.00155	0.00622	CcSEcCtD
Mianserin—Neutropenia—Dactinomycin—uterine cancer	0.00152	0.00612	CcSEcCtD
Mianserin—Angiopathy—Medroxyprogesterone Acetate—uterine cancer	0.00152	0.0061	CcSEcCtD
Mianserin—HTR2B—smooth muscle tissue—uterine cancer	0.00151	0.0197	CbGeAlD
Mianserin—Mediastinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00151	0.00606	CcSEcCtD
Mianserin—Tremor—Progesterone—uterine cancer	0.00151	0.00605	CcSEcCtD
Mianserin—Anaemia—Progesterone—uterine cancer	0.00149	0.00597	CcSEcCtD
Mianserin—HTR2B—decidua—uterine cancer	0.00148	0.0194	CbGeAlD
Mianserin—Mental disorder—Medroxyprogesterone Acetate—uterine cancer	0.00147	0.00589	CcSEcCtD
Mianserin—Bone marrow depression—Doxorubicin—uterine cancer	0.00144	0.0058	CcSEcCtD
Mianserin—Vertigo—Progesterone—uterine cancer	0.00144	0.0058	CcSEcCtD
Mianserin—Syncope—Progesterone—uterine cancer	0.00144	0.00579	CcSEcCtD
Mianserin—Loss of consciousness—Progesterone—uterine cancer	0.00141	0.00567	CcSEcCtD
Mianserin—HTR2B—endometrium—uterine cancer	0.00141	0.0184	CbGeAlD
Mianserin—Cardiac failure—Etoposide—uterine cancer	0.0014	0.00562	CcSEcCtD
Mianserin—Convulsion—Progesterone—uterine cancer	0.00139	0.00559	CcSEcCtD
Mianserin—Hypertension—Progesterone—uterine cancer	0.00139	0.00557	CcSEcCtD
Mianserin—Arthralgia—Progesterone—uterine cancer	0.00137	0.0055	CcSEcCtD
Mianserin—Myalgia—Progesterone—uterine cancer	0.00137	0.0055	CcSEcCtD
Mianserin—Tremor—Medroxyprogesterone Acetate—uterine cancer	0.00136	0.00548	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.00136	0.00546	CcSEcCtD
Mianserin—Agranulocytosis—Dactinomycin—uterine cancer	0.00136	0.00545	CcSEcCtD
Mianserin—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.00135	0.00541	CcSEcCtD
Mianserin—HTR7—epithelium—uterine cancer	0.00134	0.0175	CbGeAlD
Mianserin—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.00134	0.00538	CcSEcCtD
Mianserin—Dry mouth—Progesterone—uterine cancer	0.00134	0.00537	CcSEcCtD
Mianserin—Confusional state—Progesterone—uterine cancer	0.00132	0.00531	CcSEcCtD
Mianserin—SLC6A2—decidua—uterine cancer	0.00132	0.0172	CbGeAlD
Mianserin—Oedema—Progesterone—uterine cancer	0.00131	0.00527	CcSEcCtD
Mianserin—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.00131	0.00526	CcSEcCtD
Mianserin—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.00131	0.00525	CcSEcCtD
Mianserin—HTR1A—renal system—uterine cancer	0.00131	0.017	CbGeAlD
Mianserin—Hepatitis—Dactinomycin—uterine cancer	0.0013	0.00524	CcSEcCtD
Mianserin—Cardiac arrest—Etoposide—uterine cancer	0.0013	0.00521	CcSEcCtD
Mianserin—HTR2B—uterus—uterine cancer	0.0013	0.0169	CbGeAlD
Mianserin—HTR7—smooth muscle tissue—uterine cancer	0.0013	0.0169	CbGeAlD
Mianserin—Shock—Progesterone—uterine cancer	0.00129	0.00518	CcSEcCtD
Mianserin—Nervous system disorder—Progesterone—uterine cancer	0.00129	0.00517	CcSEcCtD
Mianserin—Tachycardia—Progesterone—uterine cancer	0.00128	0.00514	CcSEcCtD
Mianserin—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.00128	0.00514	CcSEcCtD
Mianserin—HRH1—myometrium—uterine cancer	0.00128	0.0167	CbGeAlD
Mianserin—Skin disorder—Progesterone—uterine cancer	0.00127	0.00512	CcSEcCtD
Mianserin—Blood disorder—Epirubicin—uterine cancer	0.00126	0.00507	CcSEcCtD
Mianserin—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.00126	0.00507	CcSEcCtD
Mianserin—ADRA2A—myometrium—uterine cancer	0.00126	0.0164	CbGeAlD
Mianserin—HTR1D—female reproductive system—uterine cancer	0.00125	0.0164	CbGeAlD
Mianserin—HTR7—renal system—uterine cancer	0.00125	0.0163	CbGeAlD
Mianserin—HTR2C—female reproductive system—uterine cancer	0.00124	0.0162	CbGeAlD
Mianserin—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.00124	0.00498	CcSEcCtD
Mianserin—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.00124	0.00498	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.00123	0.00495	CcSEcCtD
Mianserin—Hypotension—Progesterone—uterine cancer	0.00123	0.00492	CcSEcCtD
Mianserin—ADRA2C—uterine cervix—uterine cancer	0.00123	0.016	CbGeAlD
Mianserin—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.00121	0.00487	CcSEcCtD
Mianserin—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.0012	0.00481	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Progesterone—uterine cancer	0.00119	0.0048	CcSEcCtD
Mianserin—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.00119	0.00477	CcSEcCtD
Mianserin—Paraesthesia—Progesterone—uterine cancer	0.00118	0.00473	CcSEcCtD
Mianserin—SLC6A4—female reproductive system—uterine cancer	0.00118	0.0154	CbGeAlD
Mianserin—Shock—Medroxyprogesterone Acetate—uterine cancer	0.00117	0.0047	CcSEcCtD
Mianserin—Blood disorder—Doxorubicin—uterine cancer	0.00117	0.00469	CcSEcCtD
Mianserin—ADRA2C—decidua—uterine cancer	0.00117	0.0152	CbGeAlD
Mianserin—HTR2B—female reproductive system—uterine cancer	0.00117	0.0152	CbGeAlD
Mianserin—Somnolence—Progesterone—uterine cancer	0.00117	0.00468	CcSEcCtD
Mianserin—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00117	0.00468	CcSEcCtD
Mianserin—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.00116	0.00467	CcSEcCtD
Mianserin—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00116	0.00466	CcSEcCtD
Mianserin—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.00115	0.00464	CcSEcCtD
Mianserin—HRH2—lymph node—uterine cancer	0.00115	0.015	CbGeAlD
Mianserin—ADRA2C—renal system—uterine cancer	0.00115	0.015	CbGeAlD
Mianserin—Gastrointestinal disorder—Progesterone—uterine cancer	0.00113	0.00455	CcSEcCtD
Mianserin—Fatigue—Progesterone—uterine cancer	0.00113	0.00454	CcSEcCtD
Mianserin—Constipation—Progesterone—uterine cancer	0.00112	0.00451	CcSEcCtD
Mianserin—Pancytopenia—Etoposide—uterine cancer	0.00112	0.0045	CcSEcCtD
Mianserin—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00111	0.00446	CcSEcCtD
Mianserin—ADRA2C—endometrium—uterine cancer	0.00111	0.0145	CbGeAlD
Mianserin—Neutropenia—Etoposide—uterine cancer	0.0011	0.00443	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00108	0.00435	CcSEcCtD
Mianserin—Feeling abnormal—Progesterone—uterine cancer	0.00108	0.00434	CcSEcCtD
Mianserin—ADRA2C—mammalian vulva—uterine cancer	0.00107	0.014	CbGeAlD
Mianserin—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00107	0.00429	CcSEcCtD
Mianserin—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00106	0.00424	CcSEcCtD
Mianserin—HTR2B—vagina—uterine cancer	0.00105	0.0138	CbGeAlD
Mianserin—Anaemia—Dactinomycin—uterine cancer	0.00105	0.00422	CcSEcCtD
Mianserin—SLC6A2—female reproductive system—uterine cancer	0.00104	0.0135	CbGeAlD
Mianserin—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00103	0.00412	CcSEcCtD
Mianserin—Jaundice—Etoposide—uterine cancer	0.00103	0.00412	CcSEcCtD
Mianserin—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00102	0.00412	CcSEcCtD
Mianserin—ADRA2C—uterus—uterine cancer	0.00102	0.0133	CbGeAlD
Mianserin—Leukopenia—Dactinomycin—uterine cancer	0.00102	0.00408	CcSEcCtD
Mianserin—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00102	0.00408	CcSEcCtD
Mianserin—HRH1—epithelium—uterine cancer	0.001	0.0131	CbGeAlD
Mianserin—HTR7—female reproductive system—uterine cancer	0.000999	0.013	CbGeAlD
Mianserin—HRH1—uterine cervix—uterine cancer	0.000995	0.013	CbGeAlD
Mianserin—Hepatobiliary disease—Etoposide—uterine cancer	0.000995	0.004	CcSEcCtD
Mianserin—CYP1A2—renal system—uterine cancer	0.000995	0.013	CbGeAlD
Mianserin—Agranulocytosis—Etoposide—uterine cancer	0.000982	0.00394	CcSEcCtD
Mianserin—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000979	0.00393	CcSEcCtD
Mianserin—ADRA2A—uterine cervix—uterine cancer	0.000978	0.0128	CbGeAlD
Mianserin—HRH1—smooth muscle tissue—uterine cancer	0.000967	0.0126	CbGeAlD
Mianserin—Myalgia—Dactinomycin—uterine cancer	0.000967	0.00388	CcSEcCtD
Mianserin—CYP2B6—renal system—uterine cancer	0.000954	0.0124	CbGeAlD
Mianserin—HRH1—decidua—uterine cancer	0.000948	0.0124	CbGeAlD
Mianserin—Asthenia—Progesterone—uterine cancer	0.000941	0.00378	CcSEcCtD
Mianserin—ADRA2A—decidua—uterine cancer	0.000932	0.0122	CbGeAlD
Mianserin—Pruritus—Progesterone—uterine cancer	0.000928	0.00373	CcSEcCtD
Mianserin—Oedema—Dactinomycin—uterine cancer	0.000927	0.00372	CcSEcCtD
Mianserin—Thrombocytopenia—Dactinomycin—uterine cancer	0.000908	0.00365	CcSEcCtD
Mianserin—HRH1—endometrium—uterine cancer	0.0009	0.0117	CbGeAlD
Mianserin—ADRA2A—endometrium—uterine cancer	0.000884	0.0115	CbGeAlD
Mianserin—Eye disorder—Etoposide—uterine cancer	0.000882	0.00354	CcSEcCtD
Mianserin—Cardiac disorder—Etoposide—uterine cancer	0.000876	0.00352	CcSEcCtD
Mianserin—Hepatic function abnormal—Epirubicin—uterine cancer	0.000875	0.00352	CcSEcCtD
Mianserin—HRH1—mammalian vulva—uterine cancer	0.000871	0.0114	CbGeAlD
Mianserin—Dizziness—Progesterone—uterine cancer	0.000867	0.00348	CcSEcCtD
Mianserin—Angiopathy—Etoposide—uterine cancer	0.000857	0.00344	CcSEcCtD
Mianserin—ADRA2A—mammalian vulva—uterine cancer	0.000855	0.0112	CbGeAlD
Mianserin—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000853	0.00343	CcSEcCtD
Mianserin—Mediastinal disorder—Etoposide—uterine cancer	0.000851	0.00342	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000844	0.00339	CcSEcCtD
Mianserin—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000841	0.00338	CcSEcCtD
Mianserin—HTR2A—epithelium—uterine cancer	0.000838	0.0109	CbGeAlD
Mianserin—ADRA2C—female gonad—uterine cancer	0.000835	0.0109	CbGeAlD
Mianserin—ADRA2C—vagina—uterine cancer	0.00083	0.0108	CbGeAlD
Mianserin—Rash—Progesterone—uterine cancer	0.000827	0.00332	CcSEcCtD
Mianserin—Dermatitis—Progesterone—uterine cancer	0.000826	0.00332	CcSEcCtD
Mianserin—Headache—Progesterone—uterine cancer	0.000822	0.0033	CcSEcCtD
Mianserin—ADRA2A—uterus—uterine cancer	0.000815	0.0106	CbGeAlD
Mianserin—Hepatic function abnormal—Doxorubicin—uterine cancer	0.00081	0.00325	CcSEcCtD
Mianserin—HTR2A—smooth muscle tissue—uterine cancer	0.000808	0.0105	CbGeAlD
Mianserin—Fatigue—Dactinomycin—uterine cancer	0.000799	0.00321	CcSEcCtD
Mianserin—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000786	0.00316	CcSEcCtD
Mianserin—Cardiac failure—Epirubicin—uterine cancer	0.000784	0.00315	CcSEcCtD
Mianserin—Lethargy—Epirubicin—uterine cancer	0.000781	0.00314	CcSEcCtD
Mianserin—HTR2A—renal system—uterine cancer	0.000778	0.0101	CbGeAlD
Mianserin—Diplopia—Epirubicin—uterine cancer	0.000765	0.00307	CcSEcCtD
Mianserin—Feeling abnormal—Dactinomycin—uterine cancer	0.000764	0.00307	CcSEcCtD
Mianserin—CYP2B6—female reproductive system—uterine cancer	0.000764	0.00996	CbGeAlD
Mianserin—Anaemia—Etoposide—uterine cancer	0.00076	0.00305	CcSEcCtD
Mianserin—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000749	0.00301	CcSEcCtD
Mianserin—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000749	0.00301	CcSEcCtD
Mianserin—HRH1—female reproductive system—uterine cancer	0.000746	0.00973	CbGeAlD
Mianserin—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000744	0.00299	CcSEcCtD
Mianserin—Vertigo—Etoposide—uterine cancer	0.000738	0.00297	CcSEcCtD
Mianserin—Leukopenia—Etoposide—uterine cancer	0.000736	0.00296	CcSEcCtD
Mianserin—ADRA2A—female reproductive system—uterine cancer	0.000733	0.00956	CbGeAlD
Mianserin—Cardiac arrest—Epirubicin—uterine cancer	0.000728	0.00292	CcSEcCtD
Mianserin—Cardiac failure—Doxorubicin—uterine cancer	0.000725	0.00291	CcSEcCtD
Mianserin—Loss of consciousness—Etoposide—uterine cancer	0.000722	0.0029	CcSEcCtD
Mianserin—Lethargy—Doxorubicin—uterine cancer	0.000722	0.0029	CcSEcCtD
Mianserin—CYP3A4—renal system—uterine cancer	0.00072	0.00939	CbGeAlD
Mianserin—Convulsion—Etoposide—uterine cancer	0.000712	0.00286	CcSEcCtD
Mianserin—Hypertension—Etoposide—uterine cancer	0.00071	0.00285	CcSEcCtD
Mianserin—CYP2D6—renal system—uterine cancer	0.000709	0.00924	CbGeAlD
Mianserin—Diplopia—Doxorubicin—uterine cancer	0.000708	0.00284	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000695	0.00279	CcSEcCtD
Mianserin—Breast disorder—Epirubicin—uterine cancer	0.000691	0.00278	CcSEcCtD
Mianserin—CYP2B6—vagina—uterine cancer	0.000691	0.00901	CbGeAlD
Mianserin—HTR2B—lymph node—uterine cancer	0.000682	0.0089	CbGeAlD
Mianserin—HRH1—female gonad—uterine cancer	0.000679	0.00885	CbGeAlD
Mianserin—Confusional state—Etoposide—uterine cancer	0.000676	0.00272	CcSEcCtD
Mianserin—HRH1—vagina—uterine cancer	0.000674	0.0088	CbGeAlD
Mianserin—Cardiac arrest—Doxorubicin—uterine cancer	0.000673	0.0027	CcSEcCtD
Mianserin—ADRA2A—female gonad—uterine cancer	0.000667	0.0087	CbGeAlD
Mianserin—Asthenia—Dactinomycin—uterine cancer	0.000665	0.00267	CcSEcCtD
Mianserin—ADRA2A—vagina—uterine cancer	0.000663	0.00864	CbGeAlD
Mianserin—Thrombocytopenia—Etoposide—uterine cancer	0.000657	0.00264	CcSEcCtD
Mianserin—Tachycardia—Etoposide—uterine cancer	0.000655	0.00263	CcSEcCtD
Mianserin—Skin disorder—Etoposide—uterine cancer	0.000652	0.00262	CcSEcCtD
Mianserin—Breast disorder—Doxorubicin—uterine cancer	0.00064	0.00257	CcSEcCtD
Mianserin—Pancytopenia—Epirubicin—uterine cancer	0.000628	0.00252	CcSEcCtD
Mianserin—Hypotension—Etoposide—uterine cancer	0.000627	0.00252	CcSEcCtD
Mianserin—HTR2A—female reproductive system—uterine cancer	0.000623	0.00813	CbGeAlD
Mianserin—Neutropenia—Epirubicin—uterine cancer	0.000618	0.00248	CcSEcCtD
Mianserin—SLC6A2—lymph node—uterine cancer	0.000606	0.00791	CbGeAlD
Mianserin—Paraesthesia—Etoposide—uterine cancer	0.000602	0.00242	CcSEcCtD
Mianserin—Weight increased—Epirubicin—uterine cancer	0.000602	0.00242	CcSEcCtD
Mianserin—Somnolence—Etoposide—uterine cancer	0.000596	0.0024	CcSEcCtD
Mianserin—Drowsiness—Epirubicin—uterine cancer	0.00059	0.00237	CcSEcCtD
Mianserin—Rash—Dactinomycin—uterine cancer	0.000584	0.00235	CcSEcCtD
Mianserin—Pancytopenia—Doxorubicin—uterine cancer	0.000581	0.00233	CcSEcCtD
Mianserin—Gastrointestinal disorder—Etoposide—uterine cancer	0.000579	0.00233	CcSEcCtD
Mianserin—Fatigue—Etoposide—uterine cancer	0.000578	0.00232	CcSEcCtD
Mianserin—CYP3A4—female reproductive system—uterine cancer	0.000577	0.00752	CbGeAlD
Mianserin—Jaundice—Epirubicin—uterine cancer	0.000575	0.00231	CcSEcCtD
Mianserin—Constipation—Etoposide—uterine cancer	0.000574	0.0023	CcSEcCtD
Mianserin—Neutropenia—Doxorubicin—uterine cancer	0.000572	0.0023	CcSEcCtD
Mianserin—CYP2D6—female reproductive system—uterine cancer	0.000567	0.0074	CbGeAlD
Mianserin—HTR2A—vagina—uterine cancer	0.000563	0.00735	CbGeAlD
Mianserin—Hepatobiliary disease—Epirubicin—uterine cancer	0.000558	0.00224	CcSEcCtD
Mianserin—Weight increased—Doxorubicin—uterine cancer	0.000557	0.00224	CcSEcCtD
Mianserin—Feeling abnormal—Etoposide—uterine cancer	0.000553	0.00222	CcSEcCtD
Mianserin—Agranulocytosis—Epirubicin—uterine cancer	0.00055	0.00221	CcSEcCtD
Mianserin—Drowsiness—Doxorubicin—uterine cancer	0.000546	0.00219	CcSEcCtD
Mianserin—Bradycardia—Epirubicin—uterine cancer	0.000539	0.00216	CcSEcCtD
Mianserin—ADRA2C—lymph node—uterine cancer	0.000537	0.00701	CbGeAlD
Mianserin—Jaundice—Doxorubicin—uterine cancer	0.000532	0.00214	CcSEcCtD
Mianserin—Hepatitis—Epirubicin—uterine cancer	0.000529	0.00213	CcSEcCtD
Mianserin—Connective tissue disorder—Epirubicin—uterine cancer	0.00052	0.00209	CcSEcCtD
Mianserin—CYP2D6—female gonad—uterine cancer	0.000516	0.00674	CbGeAlD
Mianserin—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000516	0.00207	CcSEcCtD
Mianserin—Agranulocytosis—Doxorubicin—uterine cancer	0.000509	0.00205	CcSEcCtD
Mianserin—Bradycardia—Doxorubicin—uterine cancer	0.000499	0.002	CcSEcCtD
Mianserin—Eye disorder—Epirubicin—uterine cancer	0.000495	0.00199	CcSEcCtD
Mianserin—Tinnitus—Epirubicin—uterine cancer	0.000493	0.00198	CcSEcCtD
Mianserin—Cardiac disorder—Epirubicin—uterine cancer	0.000491	0.00197	CcSEcCtD
Mianserin—Hepatitis—Doxorubicin—uterine cancer	0.00049	0.00197	CcSEcCtD
Mianserin—Asthenia—Etoposide—uterine cancer	0.000481	0.00193	CcSEcCtD
Mianserin—Connective tissue disorder—Doxorubicin—uterine cancer	0.000481	0.00193	CcSEcCtD
Mianserin—Angiopathy—Epirubicin—uterine cancer	0.00048	0.00193	CcSEcCtD
Mianserin—Mediastinal disorder—Epirubicin—uterine cancer	0.000477	0.00192	CcSEcCtD
Mianserin—Pruritus—Etoposide—uterine cancer	0.000475	0.00191	CcSEcCtD
Mianserin—Mental disorder—Epirubicin—uterine cancer	0.000464	0.00186	CcSEcCtD
Mianserin—Eye disorder—Doxorubicin—uterine cancer	0.000458	0.00184	CcSEcCtD
Mianserin—Tinnitus—Doxorubicin—uterine cancer	0.000457	0.00183	CcSEcCtD
Mianserin—Cardiac disorder—Doxorubicin—uterine cancer	0.000455	0.00183	CcSEcCtD
Mianserin—Angiopathy—Doxorubicin—uterine cancer	0.000444	0.00179	CcSEcCtD
Mianserin—Dizziness—Etoposide—uterine cancer	0.000444	0.00178	CcSEcCtD
Mianserin—Mediastinal disorder—Doxorubicin—uterine cancer	0.000441	0.00177	CcSEcCtD
Mianserin—HRH1—lymph node—uterine cancer	0.000436	0.00569	CbGeAlD
Mianserin—Mental disorder—Doxorubicin—uterine cancer	0.000429	0.00172	CcSEcCtD
Mianserin—ADRA2A—lymph node—uterine cancer	0.000429	0.00559	CbGeAlD
Mianserin—Anaemia—Epirubicin—uterine cancer	0.000426	0.00171	CcSEcCtD
Mianserin—Agitation—Epirubicin—uterine cancer	0.000423	0.0017	CcSEcCtD
Mianserin—Rash—Etoposide—uterine cancer	0.000423	0.0017	CcSEcCtD
Mianserin—Dermatitis—Etoposide—uterine cancer	0.000423	0.0017	CcSEcCtD
Mianserin—Headache—Etoposide—uterine cancer	0.00042	0.00169	CcSEcCtD
Mianserin—Vertigo—Epirubicin—uterine cancer	0.000414	0.00166	CcSEcCtD
Mianserin—Syncope—Epirubicin—uterine cancer	0.000413	0.00166	CcSEcCtD
Mianserin—Leukopenia—Epirubicin—uterine cancer	0.000412	0.00166	CcSEcCtD
Mianserin—Loss of consciousness—Epirubicin—uterine cancer	0.000405	0.00163	CcSEcCtD
Mianserin—Convulsion—Epirubicin—uterine cancer	0.000399	0.0016	CcSEcCtD
Mianserin—Hypertension—Epirubicin—uterine cancer	0.000398	0.0016	CcSEcCtD
Mianserin—Anaemia—Doxorubicin—uterine cancer	0.000394	0.00158	CcSEcCtD
Mianserin—Arthralgia—Epirubicin—uterine cancer	0.000392	0.00158	CcSEcCtD
Mianserin—Myalgia—Epirubicin—uterine cancer	0.000392	0.00158	CcSEcCtD
Mianserin—Agitation—Doxorubicin—uterine cancer	0.000392	0.00157	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.00039	0.00157	CcSEcCtD
Mianserin—Dry mouth—Epirubicin—uterine cancer	0.000384	0.00154	CcSEcCtD
Mianserin—Vertigo—Doxorubicin—uterine cancer	0.000383	0.00154	CcSEcCtD
Mianserin—Syncope—Doxorubicin—uterine cancer	0.000382	0.00154	CcSEcCtD
Mianserin—Leukopenia—Doxorubicin—uterine cancer	0.000382	0.00153	CcSEcCtD
Mianserin—Confusional state—Epirubicin—uterine cancer	0.000379	0.00152	CcSEcCtD
Mianserin—Oedema—Epirubicin—uterine cancer	0.000376	0.00151	CcSEcCtD
Mianserin—Loss of consciousness—Doxorubicin—uterine cancer	0.000375	0.00151	CcSEcCtD
Mianserin—Shock—Epirubicin—uterine cancer	0.00037	0.00149	CcSEcCtD
Mianserin—Convulsion—Doxorubicin—uterine cancer	0.000369	0.00148	CcSEcCtD
Mianserin—Nervous system disorder—Epirubicin—uterine cancer	0.000369	0.00148	CcSEcCtD
Mianserin—Thrombocytopenia—Epirubicin—uterine cancer	0.000368	0.00148	CcSEcCtD
Mianserin—Hypertension—Doxorubicin—uterine cancer	0.000368	0.00148	CcSEcCtD
Mianserin—Tachycardia—Epirubicin—uterine cancer	0.000367	0.00147	CcSEcCtD
Mianserin—Skin disorder—Epirubicin—uterine cancer	0.000365	0.00147	CcSEcCtD
Mianserin—Arthralgia—Doxorubicin—uterine cancer	0.000363	0.00146	CcSEcCtD
Mianserin—Myalgia—Doxorubicin—uterine cancer	0.000363	0.00146	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.00036	0.00145	CcSEcCtD
Mianserin—Dry mouth—Doxorubicin—uterine cancer	0.000355	0.00143	CcSEcCtD
Mianserin—Hypotension—Epirubicin—uterine cancer	0.000351	0.00141	CcSEcCtD
Mianserin—Confusional state—Doxorubicin—uterine cancer	0.000351	0.00141	CcSEcCtD
Mianserin—Oedema—Doxorubicin—uterine cancer	0.000348	0.0014	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000343	0.00138	CcSEcCtD
Mianserin—Shock—Doxorubicin—uterine cancer	0.000342	0.00138	CcSEcCtD
Mianserin—Nervous system disorder—Doxorubicin—uterine cancer	0.000341	0.00137	CcSEcCtD
Mianserin—Thrombocytopenia—Doxorubicin—uterine cancer	0.000341	0.00137	CcSEcCtD
Mianserin—Tachycardia—Doxorubicin—uterine cancer	0.00034	0.00136	CcSEcCtD
Mianserin—Skin disorder—Doxorubicin—uterine cancer	0.000338	0.00136	CcSEcCtD
Mianserin—Paraesthesia—Epirubicin—uterine cancer	0.000338	0.00136	CcSEcCtD
Mianserin—Somnolence—Epirubicin—uterine cancer	0.000334	0.00134	CcSEcCtD
Mianserin—Hypotension—Doxorubicin—uterine cancer	0.000325	0.00131	CcSEcCtD
Mianserin—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000325	0.0013	CcSEcCtD
Mianserin—Fatigue—Epirubicin—uterine cancer	0.000324	0.0013	CcSEcCtD
Mianserin—Constipation—Epirubicin—uterine cancer	0.000322	0.00129	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000317	0.00127	CcSEcCtD
Mianserin—Paraesthesia—Doxorubicin—uterine cancer	0.000312	0.00126	CcSEcCtD
Mianserin—Feeling abnormal—Epirubicin—uterine cancer	0.00031	0.00124	CcSEcCtD
Mianserin—Somnolence—Doxorubicin—uterine cancer	0.000309	0.00124	CcSEcCtD
Mianserin—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.0003	0.00121	CcSEcCtD
Mianserin—Fatigue—Doxorubicin—uterine cancer	0.0003	0.00121	CcSEcCtD
Mianserin—Constipation—Doxorubicin—uterine cancer	0.000298	0.0012	CcSEcCtD
Mianserin—Feeling abnormal—Doxorubicin—uterine cancer	0.000287	0.00115	CcSEcCtD
Mianserin—Asthenia—Epirubicin—uterine cancer	0.00027	0.00108	CcSEcCtD
Mianserin—Pruritus—Epirubicin—uterine cancer	0.000266	0.00107	CcSEcCtD
Mianserin—Asthenia—Doxorubicin—uterine cancer	0.00025	0.001	CcSEcCtD
Mianserin—Dizziness—Epirubicin—uterine cancer	0.000249	0.000999	CcSEcCtD
Mianserin—Pruritus—Doxorubicin—uterine cancer	0.000246	0.000989	CcSEcCtD
Mianserin—Rash—Epirubicin—uterine cancer	0.000237	0.000953	CcSEcCtD
Mianserin—Dermatitis—Epirubicin—uterine cancer	0.000237	0.000952	CcSEcCtD
Mianserin—Headache—Epirubicin—uterine cancer	0.000236	0.000946	CcSEcCtD
Mianserin—Dizziness—Doxorubicin—uterine cancer	0.00023	0.000924	CcSEcCtD
Mianserin—Rash—Doxorubicin—uterine cancer	0.000219	0.000881	CcSEcCtD
Mianserin—Dermatitis—Doxorubicin—uterine cancer	0.000219	0.000881	CcSEcCtD
Mianserin—Headache—Doxorubicin—uterine cancer	0.000218	0.000876	CcSEcCtD
Mianserin—HTR2C—Signaling by GPCR—KRAS—uterine cancer	2.61e-06	0.000227	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—EP300—uterine cancer	2.6e-06	0.000226	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—EP300—uterine cancer	2.6e-06	0.000226	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—EP300—uterine cancer	2.58e-06	0.000224	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—CXCL8—uterine cancer	2.58e-06	0.000224	CbGpPWpGaD
Mianserin—ADRA2C—GPCR downstream signaling—PIK3CA—uterine cancer	2.57e-06	0.000223	CbGpPWpGaD
Mianserin—DRD3—Signaling by GPCR—HRAS—uterine cancer	2.56e-06	0.000223	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—CTNNB1—uterine cancer	2.56e-06	0.000222	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—KRAS—uterine cancer	2.54e-06	0.000221	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—ESR1—uterine cancer	2.54e-06	0.00022	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—CDKN1B—uterine cancer	2.52e-06	0.000219	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—PIK3CA—uterine cancer	2.51e-06	0.000218	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—STK11—uterine cancer	2.51e-06	0.000218	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—CYP19A1—uterine cancer	2.51e-06	0.000218	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—VEGFA—uterine cancer	2.5e-06	0.000217	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—PIK3CA—uterine cancer	2.5e-06	0.000217	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CCL2—uterine cancer	2.5e-06	0.000217	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—PTEN—uterine cancer	2.49e-06	0.000216	CbGpPWpGaD
Mianserin—DRD3—GPCR downstream signaling—AKT1—uterine cancer	2.49e-06	0.000216	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—AKR1C3—uterine cancer	2.48e-06	0.000216	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—NRAS—uterine cancer	2.47e-06	0.000215	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—VEGFA—uterine cancer	2.47e-06	0.000214	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—VEGFA—uterine cancer	2.46e-06	0.000214	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CCL2—uterine cancer	2.46e-06	0.000213	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—ERBB2—uterine cancer	2.45e-06	0.000213	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CCL2—uterine cancer	2.45e-06	0.000213	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—VEGFA—uterine cancer	2.45e-06	0.000213	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—AKT1—uterine cancer	2.44e-06	0.000212	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—NRAS—uterine cancer	2.44e-06	0.000212	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—NRAS—uterine cancer	2.43e-06	0.000211	CbGpPWpGaD
Mianserin—HTR2B—Signaling by GPCR—AKT1—uterine cancer	2.43e-06	0.000211	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—TP53—uterine cancer	2.43e-06	0.000211	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—NRAS—uterine cancer	2.42e-06	0.00021	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—PIK3CA—uterine cancer	2.41e-06	0.00021	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—PIK3CA—uterine cancer	2.4e-06	0.000209	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—NRAS—uterine cancer	2.4e-06	0.000208	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—CTNNB1—uterine cancer	2.38e-06	0.000207	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—EP300—uterine cancer	2.38e-06	0.000206	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—ERBB2—uterine cancer	2.37e-06	0.000206	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—ERBB2—uterine cancer	2.36e-06	0.000205	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.35e-06	0.000205	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—PTEN—uterine cancer	2.34e-06	0.000203	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—PIK3CA—uterine cancer	2.33e-06	0.000203	CbGpPWpGaD
Mianserin—DRD2—GPCR downstream signaling—PIK3CA—uterine cancer	2.33e-06	0.000203	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—CXCL8—uterine cancer	2.33e-06	0.000202	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—HRAS—uterine cancer	2.32e-06	0.000202	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—PTEN—uterine cancer	2.32e-06	0.000201	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—HRAS—uterine cancer	2.31e-06	0.000201	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—KRAS—uterine cancer	2.31e-06	0.0002	CbGpPWpGaD
Mianserin—HTR2A—GPCR downstream signaling—PIK3CA—uterine cancer	2.3e-06	0.000199	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—ERBB2—uterine cancer	2.29e-06	0.000199	CbGpPWpGaD
Mianserin—HRH1—GPCR downstream signaling—PIK3CA—uterine cancer	2.29e-06	0.000199	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—CDKN1B—uterine cancer	2.27e-06	0.000198	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—KRAS—uterine cancer	2.27e-06	0.000197	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—KRAS—uterine cancer	2.26e-06	0.000197	CbGpPWpGaD
Mianserin—DRD3—Signaling by GPCR—AKT1—uterine cancer	2.26e-06	0.000197	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—VEGFA—uterine cancer	2.25e-06	0.000196	CbGpPWpGaD
Mianserin—ADRA2B—GPCR downstream signaling—AKT1—uterine cancer	2.25e-06	0.000195	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—CXCL8—uterine cancer	2.25e-06	0.000195	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.25e-06	0.000195	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—CXCL8—uterine cancer	2.24e-06	0.000194	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CCL2—uterine cancer	2.23e-06	0.000194	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—HRAS—uterine cancer	2.23e-06	0.000194	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—EP300—uterine cancer	2.23e-06	0.000194	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—MTHFR—uterine cancer	2.22e-06	0.000193	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—NRAS—uterine cancer	2.22e-06	0.000193	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—HRAS—uterine cancer	2.22e-06	0.000193	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—EP300—uterine cancer	2.21e-06	0.000192	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—CDKN1B—uterine cancer	2.19e-06	0.000191	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—CDKN1B—uterine cancer	2.18e-06	0.00019	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CXCL8—uterine cancer	2.17e-06	0.000189	CbGpPWpGaD
Mianserin—HTR1A—GPCR downstream signaling—AKT1—uterine cancer	2.17e-06	0.000189	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—HRAS—uterine cancer	2.16e-06	0.000188	CbGpPWpGaD
Mianserin—HTR2C—GPCR downstream signaling—AKT1—uterine cancer	2.16e-06	0.000188	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—CTNNB1—uterine cancer	2.15e-06	0.000187	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—KRAS—uterine cancer	2.13e-06	0.000185	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CDKN1B—uterine cancer	2.12e-06	0.000184	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—PIK3CA—uterine cancer	2.12e-06	0.000184	CbGpPWpGaD
Mianserin—ADRA2C—GPCR downstream signaling—AKT1—uterine cancer	2.1e-06	0.000183	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—KRAS—uterine cancer	2.1e-06	0.000182	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—VEGFA—uterine cancer	2.09e-06	0.000182	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—KRAS—uterine cancer	2.09e-06	0.000182	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—PTEN—uterine cancer	2.09e-06	0.000182	CbGpPWpGaD
Mianserin—ADRA2A—GPCR downstream signaling—PIK3CA—uterine cancer	2.09e-06	0.000181	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—PIK3CA—uterine cancer	2.08e-06	0.000181	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—ERBB2—uterine cancer	2.08e-06	0.000181	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—PIK3CA—uterine cancer	2.08e-06	0.000181	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—KRAS—uterine cancer	2.08e-06	0.000181	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—CTNNB1—uterine cancer	2.07e-06	0.00018	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—NRAS—uterine cancer	2.07e-06	0.00018	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—KRAS—uterine cancer	2.06e-06	0.000179	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—CTNNB1—uterine cancer	2.06e-06	0.000179	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—AKT1—uterine cancer	2.05e-06	0.000178	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—ERBB2—uterine cancer	2.05e-06	0.000178	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—ERBB2—uterine cancer	2.04e-06	0.000177	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—AKT1—uterine cancer	2.04e-06	0.000177	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—PTEN—uterine cancer	2.02e-06	0.000176	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—PTEN—uterine cancer	2.01e-06	0.000175	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CTNNB1—uterine cancer	2.01e-06	0.000174	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—EP300—uterine cancer	2e-06	0.000173	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CXCL8—uterine cancer	1.97e-06	0.000171	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—AKT1—uterine cancer	1.97e-06	0.000171	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—AKT1—uterine cancer	1.96e-06	0.00017	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—HRAS—uterine cancer	1.96e-06	0.00017	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—PTEN—uterine cancer	1.96e-06	0.00017	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—PIK3CA—uterine cancer	1.95e-06	0.00017	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CXCL8—uterine cancer	1.94e-06	0.000169	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CXCL8—uterine cancer	1.94e-06	0.000168	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CYP19A1—uterine cancer	1.94e-06	0.000168	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—STK11—uterine cancer	1.94e-06	0.000168	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—HRAS—uterine cancer	1.93e-06	0.000168	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—EP300—uterine cancer	1.93e-06	0.000167	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CDKN1B—uterine cancer	1.93e-06	0.000167	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—PIK3CA—uterine cancer	1.93e-06	0.000167	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—HRAS—uterine cancer	1.92e-06	0.000167	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—PIK3CA—uterine cancer	1.92e-06	0.000167	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—EP300—uterine cancer	1.92e-06	0.000167	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—KRAS—uterine cancer	1.91e-06	0.000166	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—PIK3CA—uterine cancer	1.91e-06	0.000166	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—AKT1—uterine cancer	1.91e-06	0.000166	CbGpPWpGaD
Mianserin—DRD2—GPCR downstream signaling—AKT1—uterine cancer	1.91e-06	0.000166	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—PTEN—uterine cancer	1.9e-06	0.000165	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—PIK3CA—uterine cancer	1.9e-06	0.000165	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CDKN1B—uterine cancer	1.9e-06	0.000165	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CDKN1B—uterine cancer	1.89e-06	0.000164	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—VEGFA—uterine cancer	1.89e-06	0.000164	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—TP53—uterine cancer	1.89e-06	0.000164	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—MTHFR—uterine cancer	1.88e-06	0.000164	CbGpPWpGaD
Mianserin—HTR2A—GPCR downstream signaling—AKT1—uterine cancer	1.88e-06	0.000163	CbGpPWpGaD
Mianserin—HRH1—GPCR downstream signaling—AKT1—uterine cancer	1.87e-06	0.000163	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—NRAS—uterine cancer	1.87e-06	0.000162	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—EP300—uterine cancer	1.86e-06	0.000162	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—TP53—uterine cancer	1.86e-06	0.000162	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—ERBB2—uterine cancer	1.86e-06	0.000162	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—TP53—uterine cancer	1.86e-06	0.000162	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—TP53—uterine cancer	1.85e-06	0.000161	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—VEGFA—uterine cancer	1.83e-06	0.000159	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CTNNB1—uterine cancer	1.82e-06	0.000158	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—VEGFA—uterine cancer	1.82e-06	0.000158	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—EP300—uterine cancer	1.81e-06	0.000157	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—HRAS—uterine cancer	1.81e-06	0.000157	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—NRAS—uterine cancer	1.8e-06	0.000157	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—NRAS—uterine cancer	1.79e-06	0.000156	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CTNNB1—uterine cancer	1.79e-06	0.000156	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CTNNB1—uterine cancer	1.79e-06	0.000155	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—HRAS—uterine cancer	1.78e-06	0.000155	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—PTEN—uterine cancer	1.78e-06	0.000155	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—KRAS—uterine cancer	1.78e-06	0.000155	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—HRAS—uterine cancer	1.78e-06	0.000155	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—PTEN—uterine cancer	1.77e-06	0.000154	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—HRAS—uterine cancer	1.77e-06	0.000154	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CXCL8—uterine cancer	1.77e-06	0.000153	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—VEGFA—uterine cancer	1.77e-06	0.000153	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—PIK3CA—uterine cancer	1.76e-06	0.000153	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—HRAS—uterine cancer	1.75e-06	0.000152	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—PTEN—uterine cancer	1.75e-06	0.000152	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—NRAS—uterine cancer	1.74e-06	0.000152	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—PTEN—uterine cancer	1.74e-06	0.000151	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—AKT1—uterine cancer	1.73e-06	0.00015	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CDKN1B—uterine cancer	1.72e-06	0.00015	CbGpPWpGaD
Mianserin—ADRA2A—GPCR downstream signaling—AKT1—uterine cancer	1.71e-06	0.000148	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—AKT1—uterine cancer	1.7e-06	0.000148	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—TP53—uterine cancer	1.7e-06	0.000148	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—AKT1—uterine cancer	1.7e-06	0.000148	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—EP300—uterine cancer	1.7e-06	0.000148	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—EP300—uterine cancer	1.69e-06	0.000147	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—EP300—uterine cancer	1.66e-06	0.000145	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—EP300—uterine cancer	1.66e-06	0.000144	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.66e-06	0.000144	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—PIK3CA—uterine cancer	1.65e-06	0.000143	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—PIK3CA—uterine cancer	1.64e-06	0.000142	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CTNNB1—uterine cancer	1.63e-06	0.000142	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—HRAS—uterine cancer	1.63e-06	0.000141	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—KRAS—uterine cancer	1.61e-06	0.00014	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—VEGFA—uterine cancer	1.6e-06	0.000139	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—AKT1—uterine cancer	1.6e-06	0.000139	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—PTEN—uterine cancer	1.59e-06	0.000138	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—NRAS—uterine cancer	1.58e-06	0.000138	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—TP53—uterine cancer	1.58e-06	0.000137	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—VEGFA—uterine cancer	1.58e-06	0.000137	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—VEGFA—uterine cancer	1.57e-06	0.000137	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—AKT1—uterine cancer	1.57e-06	0.000137	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—AKT1—uterine cancer	1.57e-06	0.000137	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—AKT1—uterine cancer	1.56e-06	0.000136	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—NRAS—uterine cancer	1.56e-06	0.000135	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—NRAS—uterine cancer	1.55e-06	0.000135	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—KRAS—uterine cancer	1.55e-06	0.000135	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—AKT1—uterine cancer	1.55e-06	0.000135	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—KRAS—uterine cancer	1.54e-06	0.000134	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—EP300—uterine cancer	1.51e-06	0.000132	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—HRAS—uterine cancer	1.51e-06	0.000131	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—KRAS—uterine cancer	1.5e-06	0.00013	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—PIK3CA—uterine cancer	1.48e-06	0.000128	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—MTHFR—uterine cancer	1.45e-06	0.000126	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—AKT1—uterine cancer	1.44e-06	0.000125	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—VEGFA—uterine cancer	1.43e-06	0.000125	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—TP53—uterine cancer	1.43e-06	0.000124	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—PIK3CA—uterine cancer	1.43e-06	0.000124	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—PIK3CA—uterine cancer	1.42e-06	0.000123	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—NRAS—uterine cancer	1.42e-06	0.000123	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—PIK3CA—uterine cancer	1.38e-06	0.00012	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—TP53—uterine cancer	1.38e-06	0.00012	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—TP53—uterine cancer	1.37e-06	0.000119	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—HRAS—uterine cancer	1.37e-06	0.000119	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—KRAS—uterine cancer	1.36e-06	0.000118	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—AKT1—uterine cancer	1.35e-06	0.000117	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—KRAS—uterine cancer	1.34e-06	0.000116	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—PIK3CA—uterine cancer	1.34e-06	0.000116	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—KRAS—uterine cancer	1.34e-06	0.000116	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—AKT1—uterine cancer	1.34e-06	0.000116	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—TP53—uterine cancer	1.33e-06	0.000116	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—HRAS—uterine cancer	1.32e-06	0.000115	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—HRAS—uterine cancer	1.31e-06	0.000114	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—HRAS—uterine cancer	1.28e-06	0.000111	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—PIK3CA—uterine cancer	1.26e-06	0.000109	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—PIK3CA—uterine cancer	1.25e-06	0.000109	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PTEN—uterine cancer	1.24e-06	0.000108	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—PIK3CA—uterine cancer	1.23e-06	0.000107	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—PIK3CA—uterine cancer	1.23e-06	0.000107	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—KRAS—uterine cancer	1.22e-06	0.000106	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—TP53—uterine cancer	1.21e-06	0.000105	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—AKT1—uterine cancer	1.21e-06	0.000105	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—TP53—uterine cancer	1.19e-06	0.000104	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—TP53—uterine cancer	1.19e-06	0.000103	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—EP300—uterine cancer	1.18e-06	0.000103	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—AKT1—uterine cancer	1.16e-06	0.000101	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—AKT1—uterine cancer	1.16e-06	0.000101	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—HRAS—uterine cancer	1.16e-06	0.000101	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—HRAS—uterine cancer	1.14e-06	9.9e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—HRAS—uterine cancer	1.14e-06	9.88e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—AKT1—uterine cancer	1.13e-06	9.79e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—PIK3CA—uterine cancer	1.12e-06	9.73e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—AKT1—uterine cancer	1.09e-06	9.51e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—TP53—uterine cancer	1.08e-06	9.42e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PTEN—uterine cancer	1.05e-06	9.11e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—HRAS—uterine cancer	1.04e-06	9.01e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—AKT1—uterine cancer	1.03e-06	8.92e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—AKT1—uterine cancer	1.02e-06	8.88e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—AKT1—uterine cancer	1.01e-06	8.74e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—AKT1—uterine cancer	1e-06	8.72e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—EP300—uterine cancer	1e-06	8.69e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—AKT1—uterine cancer	9.15e-07	7.95e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PIK3CA—uterine cancer	8.73e-07	7.59e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PTEN—uterine cancer	8.09e-07	7.03e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—EP300—uterine cancer	7.72e-07	6.7e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PIK3CA—uterine cancer	7.4e-07	6.43e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—AKT1—uterine cancer	7.13e-07	6.2e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—AKT1—uterine cancer	6.04e-07	5.25e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PIK3CA—uterine cancer	5.71e-07	4.96e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—AKT1—uterine cancer	4.66e-07	4.05e-05	CbGpPWpGaD
